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Abstract
Background and Purpose—Low heart rate variability (HRV), a marker of cardiac autonomic 
dysfunction, has been associated with increased all-cause and cardiovascular mortality. We 
examined the association between reduced HRV and incident stroke in a community-based cohort.
Methods—The Atherosclerosis Risk in Communities (ARIC) Study measured HRV using 2-
minute electrocardiogram readings in 12,550 middle-aged adults at baseline (1987-89). HRV 
indices were calculated using the standard deviation of RR intervals (SDNN), the mean of all 
normal RR intervals (MeanNN), the root mean square of successive differences of successive RR 
intervals (RMSSD), low (LF) and high (HF) frequency power, and the LF/HF ratio. All HRV 
measures were categorized into quintiles. Incident stroke was adjudicated through 2011. Cox 
regression was used to estimate hazard ratios (HR) with the lowest HRV quintile as the reference, 
with and without stratification by prevalent diabetes.
Results—Over a median follow-up of 22 years, 816 (6.5%) participants experienced incident 
stroke. After covariate adjustment, there was no strong evidence of association between HRV and 
stroke risk. In stratified analyses, the lowest HRV quintile was associated with higher stroke risk 
compared to the highest quintile for SDNN (HR = 2.0, 95% CI = 1.1-4.0), RMSSD (HR = 1.7, 95% 
CI = 0.9-3.2), LF (HR = 1.5, 95% CI = 0.8-3.0), and HF (HR = 1.7, 95% CI = 0.9-3.0) only among 
people with diabetes.
Conclusions—Lower HRV was associated with higher risk of incident stroke among middle-
aged adults with prevalent diabetes, but not among people without diabetes.
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INTRODUCTION
Stroke is the most severe form of cerebrovascular disease, with 795,000 cases in the U.S. 
each year.1 Stroke is the fourth leading cause of death in the U.S., leaving 50% of survivors 
disabled.2 In 2008 the U.S. spent $18.8 billion on healthcare for strokes, and $15.5 billion 
was lost in productivity.1,2 Numerous studies have identified risk factors for incident stroke 
– the most prominent being older age, male sex, African American vs. White race, 
hypertension, diabetes, obesity, and smoking.3 More recently, autonomic nervous system 
(ANS) dysfunction has been associated with increased post-stroke morbidity and mortality.4 
Proposed mechanisms include the influence of the ANS on cerebral circulatory 
autoregulation, blood pressure, and essential hypertension.5–7
Heart rate variability (HRV) is a commonly examined marker for ANS dysfunction.8 Heart 
rate is regulated by a balance between the sympathetic and parasympathetic nervous 
systems, consequently ANS dysfunction leads to measurable differences in heart rate and 
HRV.8 Low HRV has been positively associated with cardiovascular disease risk factors, and 
multiple cardiovascular outcomes including cardiovascular mortality and incident coronary 
heart disease among others.9–11 The association between HRV and cardiovascular outcomes 
has been shown to be stronger in people with diabetes.10,11
A previous study has identified an association between low HRV and the risk of all-cause 
mortality and cardiovascular mortality in older stroke survivors.12 Another study reported an 
association between low nighttime HRV and increased risk of incident ischemic stroke,13 but 
was limited by small sample size and few stroke events. The clinical value of HRV for 
identifying people at high risk of stroke is unknown; no studies have evaluated daytime HRV 
as would be assessed in a routine clinic visit. These unresolved questions have clinical and 
public health implications as HRV may represent a target for stroke prevention through 
medication or lifestyle changes that improve or preserve ANS function.14 Furthermore, 
identification of high-risk groups could prove valuable for stroke prevention. We analyzed 
data from the Atherosclerosis Risk in Communities (ARIC) cohort study to estimate the 
association between HRV and primary incident stroke.
METHODS
Study Population
The ARIC study is a longitudinal prospective cohort study initiated in 1987-89. Originally, 
15,792 men and women ages 45-64 years of age were recruited from 4 U.S. communities: 
suburbs of Minneapolis, Minnesota; Jackson, Mississippi; Washington County, Maryland; 
and Forsyth County, North Carolina. Four follow-up visits were conducted: visit 2 
(1990-92), visit 3 (1993-95), visit 4 (1996-98), and visit 5 (2011-13).15 At each study, visit 
participants underwent extensive clinical exams; visits 1 and 4 included electrocardiogram 
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(ECG) assessment of HRV. Written informed consent was collected from all study 
participants and all affiliated Institutional Review Boards approved the study protocol.
Heart Rate Variability Assessment
The Task Force of The European Society of Cardiology and others have documented 
standards and procedures for HRV measurement. In short, heart rate is measured from the 
intervals between R waves of successive heartbeats (RR interval); HRV reflects the 
magnitude of RR interval variation over time.8,16 Protocols for data processing and analysis 
in ARIC have been previously published (online supplement, eTables I and II, please see 
http://stroke.ahajournals.org).10,17 Briefly, ARIC measured HRV twice: (i) 2-minute ECG 
readings at visit 1, and (ii) 6-minute ECG readings at visit 4. All data were collected on 
resting participants in a supine position, reflect short-term daytime HRV, and were analyzed 
using ECG software (time-domain) or a previously developed computer algorithm 
(frequency-domain).10,17,18 Our primary analysis used visit 1 HRV measures, with 
secondary analyses using visit 4 HRV measures and participants who remained stroke-free at 
that exam. HRV indices are commonly divided into time- and frequency-domain 
measurements. Time-domain measures are calculated directly from heart rate or the duration 
between successive RR intervals. Frequency-domain measures are calculated from spectral 
imaging of the ECG recording. We evaluated three time-domain measures of HRV: (i) the 
standard deviation of all normal-to-normal (NN) RR intervals (SDNN) which characterizes 
overall HRV, (ii) the mean of all RR intervals (MeanNN), and (iii) the root mean square of 
successive differences in RR intervals (RMSSD) which is thought to reflect parasympathetic 
nervous system activity. We also evaluated three frequency-domain measures of HRV: (i) 
low frequency power (LF; 0.04-0.15 Hz), considered to include both sympathetic and 
parasympathetic nervous system activity, (ii) high frequency power (HF; 0.15-0.40 Hz), 
thought to reflect parasympathetic nervous system activity, and (iii) low:high frequency 
power ratio (LF:HF), which estimates the balance between sympathetic and parasympathetic 
nervous system activity.8
Incident Stroke Ascertainment
Stroke events were identified between visit 1 (1987-89) and December 31, 2011.19 Annual 
telephone calls to study participants assessed hospitalizations and deaths possibly attributed 
to strokes in the previous year. In addition, hospital discharge summaries were reviewed for 
International Classification of Diseases, 9th Revision (ICD-9) codes 430-436 which are 
indicative of cerebrovascular events, and state death registries were reviewed for 
cerebrovascular-related mortality. Study personnel documented whether hospital discharge 
ICD-9 codes included cerebrovascular disease, if cerebrovascular disease was noted in the 
discharge summary, or a cerebrovascular finding was referenced in the neuroimaging report 
study. Study staff then abstracted, from the hospital record, stroke signs and symptoms and 
findings from cerebrovascular imaging (computed tomography or magnetic resonance). 
Based on National Survey of Stroke criteria,20 a computer algorithm and study physician 
categorized all possible incident stroke events; an additional study reviewer adjudicated 
discrepancies. For the present analysis, incident stroke included ischemic and hemorrhagic 
strokes defined by the presence of an acute infarction or hemorrhage respectively on 
neurological imaging or autopsy.
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Covariates
Sociodemographic and lifestyle variables in our primary (visit 1) and secondary (visit 4) 
analyses included ARIC field site, age in years at the clinic exam, sex, race (African 
American, White), total years of education (less than completed high school, completed high 
school or equivalent, and at least some college), cigarette smoking and alcohol consumption 
(both coded as current, former, never), and physical activity (score of leisure time sports 
activity). Clinical variables included body mass index (BMI), systolic blood pressure (SBP), 
diastolic blood pressure (DBP), self-reported current use of antihypertensive medication, 
blood lipids, and diabetes (fasting glucose ≥ 126 mg/dL, non-fasting glucose ≥ 200 mg/dL, 
currently taking medication for diabetes, or self-reported physician diagnosis of diabetes).15 
SBP, DBP, and use of antihypertensive medication were excluded as covariates in sensitivity 
analyses.
Exclusions and Missing Data
Of the 15,792 participants at visit 1, we excluded individuals for the following reasons: 1) 
racial identification of Asian, American Indian, “Other,” or African American race from the 
predominantly white ARIC field sites (n = 103); 2) taking medication known to affect HRV 
(beta-blockers, antiarrythmics, calcium channel blockers, or digoxin; n = 2259); 3) prevalent 
stroke at the baseline exam (n = 204); and 4) prevalent coronary heart disease or heart failure 
(n = 676). Our final sample size was 12,550 observations. An additional 2667 individuals 
would have been excluded due to missing HRV data at baseline. To preserve sample size and 
minimize the possibility of selection bias, we used multiple imputation by chained equations 
(MICE) with 100 repetitions to impute missing data for the 2667 people who would have 
been excluded in a complete case analysis based on missing HRV data.21
Statistical Analysis
Cox proportional hazards regression was used to estimate hazard ratios (HR) for the 
relationship between each HRV measure and incident stroke. Person-time was calculated as 
number of years from the visit 1 exam to date of incident stroke or censoring (either death, 
loss to follow-up, or administrative censoring on December 31, 2011). Due to non-linear 
trends observed in preliminary descriptive analyses and a restricted cubic spline analysis, we 
categorized each HRV measure into quintiles (highest category serving as the reference for 
all comparisons).
In the primary analysis we fit two adjusted models: (i) Model 1 adjusted for baseline age, 
sex, and race, and (ii) Model 2 additionally adjusted for other baseline lifestyle and clinical 
covariates (Model 1 + education, smoking, alcohol consumption, physical activity, body 
mass index, SBP, DBP, blood lipids, prevalent diabetes, antihypertensive medication, and 
heart rate (except MeanNN)). We excluded heart rate from models for the mean RR interval 
(MeanNN) because of collinearity. Due to concerns that hypertension could be a possible 
mediator between HRV and stroke, we performed a sensitivity analysis excluding SBP, DBP, 
and antihypertensive use. Results were nearly identical; we included blood pressure 
variables in our models to address any possibility of confounding effects of blood pressure 
on the relationship between HRV and risk of incident stroke. Previous studies examining the 
association between HRV and heart disease reported effect modification by diabetes 
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status.10,11 Therefore, we evaluated statistical evidence for interaction in the full model and 
estimated stratified associations by diabetes prevalence at baseline. All results for our 
primary analysis incorporate imputed data using MICE.
In secondary analyses we evaluated the association between 6-minute HRV measured at visit 
4 and subsequent stroke; we examined statistical evidence for interaction and estimated 
stratified associations by prevalent diabetes status. The latter analysis was restricted to 
cohort members who were stroke-free at their visit 4 exam. Because results between the 
complete case analysis and non-imputed data set in our primary analysis (visit 1) were 
similar, we did not perform MICE for our sensitivity analysis for visit 4. We tested all 
models and detected no evidence of violation of the proportional hazard assumption. We 
used Stata version 14 and R for data management and statistical analyses.22,23
RESULTS
Of the 12,550 ARIC participants included in our analysis at visit 1, 6.5% (n = 816) 
experienced a stroke during follow-up. Table 1 shows descriptive statistics for baseline 
variables presented separately by SDNN quintile. In general groups with lower SDNN values 
tended to have higher proportions of females, lower education, and higher blood pressure, 
heart rate, and proportions of people with hypertension and taking antihypertensive 
medication. Groups with lower SDNN tended to have higher proportions of people with 
prevalent diabetes, with a strikingly higher proportion in the lowest SDNN quintile. Crude 
cumulative stroke incidence was consistent with higher risk in the lowest HRV quintiles 
(online supplement, Figure, please see http://stroke.ahajournals.org). Ranges for all HRV 
measurements by quintile are reported in the online supplement, eTable III, please see http://
stroke.ahajournals.org.
In Cox regression analysis for the full cohort (Table 2), people in the lowest HRV quintiles 
showed higher risk of stroke compared to the reference group in demographic-adjusted 
models, but these associations were attenuated after full covariate adjustment. Only the 
interaction between prevalent diabetes and SDNN was statistically significant (Table 3). 
Stratified analyses restricted to people with diabetes consistently showed higher stroke risk 
associated with the lowest HRV quintiles for SDNN (HR = 2.0, 95% CI = 1.1-4.0), RMSSD 
(HR = 1.7, 95% CI = 0.9-3.2), LF (HR = 1.5, 95% CI = 0.8-3.0), and HF (HR = 1.7, 95% CI 
= 0.9-3.0). Importantly, there was substantial variability among the quintiles for many of 
these outcomes (Table 3). No associations were evident for MeanNN or the LF/HF ratio 
among people with diabetes, and no relationship between HRV and incident stroke was 
evident for any measure among people without diabetes. Despite the fact that not all of these 
results were statistically significant, the lowest values of HRV were consistently associated 
with increased risk of incident stroke across most HRV measures among diabetics. 
Excluding heart rate or blood pressure variables (SBP, DPB, and antihypertensive use) 
resulted in negligible changes to point estimates and confidence intervals. We observed 
similar results for the sensitivity analysis using HRV measured at visit 4 (online supplement, 
eTable IV, please see http://stroke.ahajournals.org); of the 8041 ARIC participants included 
in this analysis, 4.6% (n=372) experienced a stroke during follow-up.
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DISCUSSION
In this prospective population-based analysis of ARIC participants, we found some evidence 
of increased risk of stroke among diabetic participants in the lowest quintile of HRV relative 
to those in the highest quintile. We observed little evidence of an association between low 
HRV and incident stroke among non-diabetic participants. These results were consistent 
across most, but not all, of the time- and frequency-domain HRV measures.
One previous study reported a positive association between low nighttime HRV (15-minute 
recording) and incident ischemic stroke.13 Though informative, this study was limited by a 
small sample size, few stroke events, and examination of time-domain HRV measures only. 
We have expanded on this work by utilizing a large prospective bi-racial cohort, time- and 
frequency-domain HRV indices, and by evaluating potential effect modification by diabetes 
status.
Individuals with type 2 diabetes are known to have an elevated risk of cardiovascular 
disease; previous studies have found positive associations between elevated fasting insulin or 
type 2 diabetes and ANS dysfunction.24 Our results are consistent with previous findings in 
ARIC in which diabetes was found to be an effect modifier: participants with diabetes in the 
lowest quartile of HRV had an elevated risk of incident coronary heart disease compared to 
those in the highest quartile; no association was observed among people without diabetes.11
The primary mechanisms providing insight into a possible association of HRV and incident 
stroke include circulatory autoregulation5,25 and blood pressure.7,19 First, the dynamics 
between blood pressure and blood flow in the cerebral vessels, circulatory autoregulation, 
are essential for brain health. The sympathetic nervous system plays a critical role in 
circulatory autoregulation; slow pressure and blood flow changes are physiologically 
controlled, whereas fast changes are not closely regulated.5,25 It is unknown how HRV 
impacts changes in cerebral vascular pressure; it is possible low HRV triggers fast pressure 
changes in cerebral vasculature, goes unregulated, and impacts vascular health and 
subsequent stroke risk. Second, hypertension presents another possible mechanism linking 
HRV and stroke. The onset and progression of hypertension are a result of elevated 
sympathetic tone.7,8 Furthermore, arterial stiffness and left ventricular hypertrophy (LVH) 
are a result of increased ANS activity; both increase vascular resistance, a known contributor 
to hypertension.26 We were initially concerned that blood pressure variables were possible 
mediators in the association between HRV and incident stroke. Simultaneously, hypertension 
is an established risk factor for incident stroke27 and is known to be associated with 
autonomic dysfunction.28 We performed a sensitivity analysis examining results with blood 
pressure variables excluded from the models. The results from the sensitivity and main 
analyses were quite similar. To be conservative, we retained blood pressure variables in our 
models to address any potential confounding effects of blood pressure on the relationship 
between HRV and risk of incident stroke. Finally, despite the fact that we did not find an 
association between low HRV and incident stroke in our primary analysis, these mechanisms 
may become physiologically relevant when other disease processes, such as diabetes, are 
present. Previous studies report that low HRV precedes coronary heart disease10 and 
mortality post-myocardial infarction.9 These same studies have hypothesized that low HRV 
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may be an early indicator of declining health. If low HRV reflects poor general health, it is 
possible that autonomic dysfunction has more impact in populations already at risk (i.e. type 
2 diabetes).
Strengths of this study include the use of a prospective design with long-term follow-up, a 
large sample size, and multiple imputation methods to minimize the possibility of selection 
bias. In addition, the present study used a community-based bi-racial cohort, measurement 
of multiple time and frequency domain HRV indices, and comprehensive collection of 
cardiovascular risk factors for confounding adjustment. HRV and incident stroke were both 
objectively measured for all analyses. Secondary analyses using 6-minute ECG recordings at 
visit 4 (online supplement, eTable IV, please see http://stroke.ahajournals.org) yielded nearly 
identical results to the primary analysis (Table 3). There are a number of limitations of this 
study. First, HRV was measured using a 2-minute and 6-minute ECG at visits 1 and 4 
respectively. Collection of long-term (>18 hours) Holter ECG recordings is generally 
preferred to short-term (~5 minutes) ECG recordings because length of ECG recording 
impacts measurement variability.16 Our results, however, did not change using 2-minute 
(visit 1) and 6-minute (visit 4) ECG data giving confidence to minimal measurement error. 
Furthermore, previous studies have demonstrated that 2-minute, 15-minute, and 24-hour 
HRV indices are correlated (most ≥ 0.75).9 A more robust measurement of HRV (24-hour 
Holter ECG) could have yielded a more accurate measure of HRV. Second, it should be 
noted that our data reflect daytime HRV, and may not represent the overall variations of 
sympathetic and parasympathetic activity that occur in a 24-hour period. Third, although 
losses to follow-up are relatively small in ARIC the possibility of selection bias exists; the 
association we report may not be generalizable. Fourth, there is considerable imprecision in 
many of our hazard ratios and studies with more events may help estimate the associations 
more accurately. Finally, despite our attempts to statistically adjust for known confounders, 
residual confounding may be present.
Implications
Identification of new indicators that contribute to incident stroke provides the opportunity to 
identify individuals at high risk and develop protocols for early intervention. Although 
newer guidelines for HRV assessment in diabetics have been proposed,29 current guidelines 
recommend measuring HRV in two situations: (i) to measure risk of mortality in individuals 
post-myocardial infarction, and (ii) to examine possible autonomic neuropathy in individuals 
with diabetes.8 Since these guidelines were published nearly two decades ago, lower HRV 
has consistently been found to predict cardiovascular disease morbidity and mortality.9–11 
Expanding the clinical scope and relevance of HRV may be warranted.
SUMMARY/CONCLUSIONS
In conclusion, in this large community-based bi-racial cohort lower HRV was associated 
with a modest risk of incident stroke in persons with diabetes, independent of traditional 
cardiovascular risk factors. Further studies are warranted, and additional exploration of the 
etiology of cardiac autonomic dysfunction and stroke in individuals with diabetes may be 
beneficial.
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Table 1
Baseline (visit 1) characteristics for study sample by SDNN quintile, ARIC, 1987-89 (n=12,550).
SDNN Quintile
Category 1 2 3 4 5
Range, ms 0.5-23.4 23.5-30.4 30.5-38.0 38.1-49.5 49.6-394
N total 2519 2512 2510 2504 2505
Age, mean years (SD) 55 (6) 54 (6) 54 (6) 53 (6) 53 (6)
Female, % 61 59 56 54 49
Black race, % 28 24 25 26 29
Education (total years), %
    Less than completed high school 25 22 22 20 21
    Completed high school or equivalent 41 41 42 43 39
    At least some college 34 37 36 37 40
Cigarette smoking, %
    Current 27 26 25 26 28
    Former 30 31 31 33 32
    Never 44 44 44 41 41
Alcohol consumption, %
    Current 54 59 56 60 59
    Former 19 15 18 17 18
    Never 27 26 26 23 23
Sport PA, mean score (SD) 2.4 (0.8) 2.4 (0.8) 2.4 (0.8) 2.5 (0.9) 2.5 (0.9)
Body mass index, mean kg/m2 (SD) 28 (6) 27 (6) 27 (6) 27 (5) 27 (5)
Systolic BP, mean mmHg (SD) 124 (21) 121 (19) 120 (18) 119 (19) 118 (19)
DiastolicBP, mean mmHg (SD) 75 (12) 74 (11) 73 (12) 73 (12) 72 (12)
Heart rate, mean beats per minute (SD) 74 (12) 68 (10) 67 (9) 65 (9) 62 (9)
HDL, mean mg/dL (SD) 53 (19) 54 (18) 53 (18) 53 (18) 52 (18)
LDL, mean mg/dL (SD) 139 (43) 137 (42) 136 (42) 137 (41) 135 (41)
Antihypertensive medication, % 25 16 15 14 14
Prevalent hypertension, % 35 26 24 22 21
Prevalent diabetes, % 17.1 9.8 7.9 7.2 6.5
Abbreviations: Standard deviation of all normal-to-normal RR intervals SDNN; standard deviation, SD; physical activity, PA; kilograms/
meter squared, kg/m2; blood pressure, BP; millimeters of mercury, mmHg; high-density lipoprotein cholesterol, HDL; low-density 
lipoprotein cholesterol, LDL; milligrams/deciliter, mg/dL.
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Table 2
Time-domain (top) and frequency-domain (bottom) heart rate variability at visit 1 and stroke risk. Total n = 
12,550; split into approximately 2510 observations per quintile for each HRV measure; total strokes n = 816.
Time-Domain
Model 1 Model 2
SDNN MeanNN RMSSD SDNN MeanNN RMSSD
Contrast HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
Quintile 1 1.4 (1.1, 1.7) 1.7 (1.3, 2.1) 1.4 (1.2, 1.8) 1.0 (0.8, 1.3) 1.2 (0.9, 1.5) 1.1 (0.8, 1.4)
Quintile 2 1.0 (0.8, 1.3) 1.3 (1.0, 1.6) 0.9 (0.7, 1.2) 0.9 (0.7, 1.2) 1.0 (0.8, 1.3) 0.8 (0.7, 1.1)
Quintile 3 1.1 (0.9, 1.4) 1.2 (0.9, 1.5) 1.1 (0.9, 1.4) 1.1 (0.8, 1.3) 1.1 (0.8, 1.4) 1.1 (0.8, 1.4)
Quintile 4 1.0 (0.7, 1.2) 1.1 (0.9, 1.4) 1.1 (0.9, 1.4) 0.9 (0.7, 1.2) 1.0 (0.8, 1.3) 1.1 (0.9, 1.4)
Quintile 5 Ref Ref Ref Ref Ref Ref
Frequency-Domain
Model 1 Model 2
LF HF LF:HF LF HF LF:HF
Contrast HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
Quintile 1 1.3 (1.0, 1.7) 1.2 (0.9, 1.5) 1.1 (0.9, 1.4) 1.1 (0.8, 1.4) 1.0 (0.8, 1.3) 1.0 (0.8, 1.3)
Quintile 2 1.2 (1.0, 1.6) 0.9 (0.7, 1.1) 1.0 (0.8, 1.2) 1.2 (0.9, 1.5) 0.9 (0.7, 1.1) 0.9 (0.7, 1.2)
Quintile 3 1.0 (0.8, 1.4) 1.0 (0.8, 1.3) 1.0 (0.8, 1.3) 1.0 (0.8, 1.3) 1.0 (0.8, 1.3) 1.0 (0.8, 1.2)
Quintile 4 1.1 (0.9, 1.5) 0.9 (0.7, 1.2) 0.9 (0.7, 1.1) 1.1 (0.8, 1.4) 0.9 (0.7, 1.2) 0.8 (0.7, 1.1)
Quintile 5 Ref Ref Ref Ref Ref Ref
Abbreviations: Hazard ratio, HR; confidence interval, CI; reference quintile, Ref.
Model 1: adjusted for age, sex, and race.
Model 2: Model 1 + education, smoking, alcohol consumption, physical activity, body mass index, systolic and diastolic blood pressure, 
blood lipids, prevalent diabetes, antihypertensive use, and heart rate (except for MeanNN).
Hazard ratios can be interpreted as the comparison between quintiles 1, 2, 3, and 4 with quintile 5 (reference).
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Table 3
Time-domain (top) and frequency-domain (bottom) heart rate variability at visit 1 and stroke risk for people 
without (n = 11,237) and with (n = 1196) prevalent diabetes; total strokes n = 816.
Time Domain
SDNN MeanNN RMSSD
No diabetes Diabetes No diabetes Diabetes No diabetes Diabetes
HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
Quintile 1 0.9 (0.6, 1.2) 2.0 (1.1, 4.0) 1.1 (0.9, 1.5) 1.1 (0.6, 1.8) 1.0 (0.7, 1.3) 1.7 (0.9, 3.2)
Quintile 2 0.9 (0.7, 1.2) 1.2 (0.6, 2.4) 1.0 (0.8, 1.4) 0.9 (0.5, 1.5) 0.7 (0.5, 1.0) 1.5 (0.8, 2.7)
Quintile 3 1.0 (0.7, 1.3) 1.7 (0.9, 3.4) 1.1 (0.9, 1.4) 0.9 (0.5, 1.6) 1.1 (0.8, 1.4) 1.0 (0.5, 2.0)
Quintile 4 0.9 (0.7, 1.2) 1.1 (0.5, 2.4) 1.1 (0.8, 1.4) 0.7 (0.3, 1.3) 1.0 (0.8, 1.3) 1.6 (0.9, 3.0)
Quintile 5 Ref Ref Ref Ref Ref Ref
p interaction 0.01 0.56 0.14
Frequency Domain
Low frequency High frequency Low frequency/High frequency
No diabetes Diabetes No diabetes Diabetes No diabetes Diabetes
HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
Quintile 1 0.9 (0.7, 1.3) 1.5 (0.8, 3.0) 0.9 (0.6, 1.2) 1.7 (0.9, 3.0) 1.0 (0.8, 1.3) 1.0 (0.6, 1.6)
Quintile 2 1.1 (0.8, 1.4) 1.5 (0.8, 2.9) 0.8 (0.6, 1.1) 1.2 (0.6, 2.2) 0.9 (0.7, 1.2) 0.8 (0.5, 1.3)
Quintile 3 1.0 (0.7, 1.3) 1.2 (0.6, 2.4) 1.0 (0.7, 1.3) 1.2 (0.7, 2.3) 1.0 (0.8, 1.4) 0.8 (0.4, 1.4)
Quintile 4 1.1 (0.8, 1.5) 1.0 (0.5, 2.2) 0.9 (0.7, 1.2) 0.9 (0.5, 1.8) 0.9 (0.7, 1.1) 0.8 (0.4, 1.3)
Quintile 5 Ref Ref Ref Ref Ref Ref
p interaction 0.10 0.06 0.81
Abbreviations: Hazard ratio, HR; confidence interval, CI; reference quintile, Ref.
All results from Model 2: adjusted for age, sex, race, education, smoking, alcohol consumption, physical activity, body mass index, systolic 
and diastolic blood pressure, blood lipids, prevalent diabetes, antihypertensive use, and heart rate (except for MeanNN).
Hazard ratios can be interpreted as the comparison between quintiles 1, 2, 3, and 4 with quintile 5 (reference).
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